C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
11/2006
11/07/2006	CA2284775C Preparation of low-dust stabilisers
11/02/2006	WO2006115168A1 N-substituted phenylacetamide derivative and pharmaceutical composition comprising the same
11/02/2006	WO2006114262A1 Acetylene derivatives
11/02/2006	WO2006093823A9 2- [ isoquinolin-s - carbonyl ) amino] -propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis
11/02/2006	US20060247289 Certain chemical entities, compositions, and methods
11/02/2006	US20060247274 N,N-bis(3-Phenoxycinnamyl)Glu(O-t-Bu)-OMe; demonstrate competitive binding with the natural ligand; ease administration, cost less and facilitate patient compliance; USEFUL IN TREATMENT OF DISEASES OR CONDITIONS ASSOCIATED WITH ERYTHROPOIETIN RECEPTOR
11/02/2006	US20060247264 Modulators of the Glucocorticoid Receptor
11/02/2006	US20060247260 Bis (hetero) aryl carboxamide derivatives for use as PG12 antagonists
11/02/2006	US20060246482 Linker molecules for selective metallisation of nucleic acids and their uses
11/02/2006	EP1716100A2 Therapeutic amide derivatives
11/02/2006	EP1401801B1 Selective androgen receptor modulators and methods of use thereof
11/02/2006	CA2605351A1 N-substituted phenylacetamide derivative and pharmaceutical composition comprising the same
11/02/2006	CA2605265A1 Acetylene derivatives
11/01/2006	CN1856565A Detergent compositions and processes for the production thereof
11/01/2006	CN1856461A Cycloalkylidene compounds as modulators of estrogen receptor
11/01/2006	CN1282640C N-arylphenylacetamide derivatives and medicinal compositions containing same
11/01/2006	CN1282494C Process for obtaining organic and from organic acid ammonium salt, an organic acid amide, or alkylamine organic acid complex
10/2006
10/31/2006	CA2262906C Novel immunotherapeutic agents and their use in the reduction of cytokine levels
10/26/2006	WO2006111771A2 Object, apparatus and process for removing, destroying or reducing the growth of organic material
10/26/2006	WO2006111234A1 Uv protection
10/26/2006	WO2006111233A1 Antioxidants
10/26/2006	US20060241180 Selective androgen receptor modulators and methods of use thereof
10/26/2006	US20060240988 Fungicides
10/26/2006	US20060240097 (4-[((6E)-8-Methylnon-6-enoylamino)methyl]-2-methyoxyphenyl formate), for example; treatment of pain associated with postherpetic neuralgia, diabetic neuropathy, HIV-associated neuropathy, complex regional pain syndrome, cancer, nerve injury, cancer chemotherapy
10/26/2006	US20060239952 Cleaning composition and method for preparing the same
10/25/2006	EP1713823A2 Hcv ns-3 serine protease inhibitors
10/25/2006	EP1713822A2 Hcv ns-3 serine protease inhibitors
10/25/2006	EP1713466A2 Antiparasitic composition containing an organic amine salt of closantel
10/25/2006	EP1265849B1 Compounds and methods to treat alzheimer's disease
10/25/2006	CN1850787A Supermolecular intercalation 2-phenylbenzimidazole-5-sulfonic acid, and its preparing method and use
10/25/2006	CN1281579C N-methyl (p-phenoxy, phenoxy) acetamide and its preparation method
10/24/2006	US7126027 N-[(1-dimethylaminocycloalkyl)methyl]benzamide derivatives
10/24/2006	US7125991 Compounds derived from benzoic acid esters, composition containing said compounds and use thereof
10/24/2006	US7125910 Compounds and compositions for delivering active agents
10/24/2006	US7125869 Drugs for cosmetics for treatment of cardiovadcular disorders, receptors, immunology or lipid metabolism
10/24/2006	US7125852 Geranyl compounds
10/24/2006	CA2367876C The preparation of e-oxime ethers of phenylglyoxylic esters
10/24/2006	CA2363690C Hsv primase inhibitors
10/19/2006	WO2006108632A1 Method for producing acetoacetic acid arylamides
10/19/2006	WO2005089354A3 Apparatus and method for applying variable localized pressure to the human body
10/19/2006	WO2005087700A3 Bisphenyl compounds useful as vitamin d3 receptor agonists
10/19/2006	US20060235239 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
10/19/2006	US20060235074 Matrix metalloproteinase inhibitors
10/19/2006	US20060235057 Phenyl compounds
10/19/2006	US20060235027 Inhibitors of cdc25 phosphatases
10/18/2006	EP1712544A1 Process for the Preparation of N-Arylamides of Acetoacetic Acid
10/18/2006	EP1711481A2 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
10/18/2006	EP1086072B1 Process for the preparation of protected dihydroxypropyl trialkylammonium salts and derivatives thereof
10/18/2006	CN1849117A Entry inhibitors of the HIV virus
10/18/2006	CN1279902C Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
10/17/2006	US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc
10/17/2006	US7122543 Substituted benzoic acid derivatives having NF-κB inhibiting action
10/17/2006	CA2318527C Inhibitors of .alpha.4 mediated cell adhesion
10/12/2006	WO2006106727A1 Benzyloxypropylamine derivative
10/12/2006	WO2005095326A8 2-amino- and 2-thio-substituted 1,3-diaminopropanes
10/12/2006	CA2603030A1 Benzyloxypropylamine derivative
10/11/2006	EP1710238A1 Benzophenones as inhibitors of reverse transcriptase
10/11/2006	EP1709155A2 Compounds and compositions for treating dysproliferative diseases, and methods of use thereof
10/11/2006	EP1708698A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
10/11/2006	CN1844088A N-methyl-2-(4-phenoxy)-2-chloracetamide and its preparing process
10/10/2006	US7119229 Having anticancer, anti-proliferous and anti-inflammatory effects and immunosuppressive and muscle relaxing functions
10/10/2006	CA2268799C Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same
10/05/2006	WO2005065361A3 Compounds and compositions for treating dysproliferative diseases, and methods of use thereof
10/05/2006	US20060223726 Photo-labile pro-fragrance conjugates
10/05/2006	CA2606303A1 Alkylated and polymeric macromolecular antioxidants and methods of making and using the same
10/04/2006	EP1706372A1 Alpha-hydroxy amides as bradykinin antagonists or inverse agonists
10/04/2006	EP1534658A4 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
10/04/2006	EP1377290B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/03/2006	US7115750 Melanin concentrating hormone antagonist
10/03/2006	CA2489834C Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
09/2006
09/28/2006	WO2006102423A1 Alpha ketoamide compounds as cysteine protease inhibitors
09/28/2006	WO2006074244A3 Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
09/28/2006	WO2005016240A3 Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same
09/28/2006	US20060217434 1-((4,14-(Dioxo),5-(1-hydroxy,1,2-dicarboxyethyl)),3-azaoctadec-6-enyl-),4-(phenoxy)benzene derivatives and salts ; extremely potent replication inhibitory activity against the hepatitis C virus (HCV); chronic hepatitis, cirrhosis and liver cancer; mild cytotoxicity in vitro; prophylaxis; prodrugs
09/28/2006	US20060217372 Diaryl ethers as opioid receptor antagonist
09/28/2006	US20060217346 Fungicides
09/28/2006	CA2603305A1 Alpha ketoamide compounds as cysteine protease inhibitors
09/27/2006	EP1705174A1 Selective androgen receptor modulators and methods of use thereof
09/27/2006	EP1704856A1 Hsp90 family protein inhibitor
09/27/2006	EP1704135A1 Propofol analogs, process for their preparation, and methods of use
09/27/2006	EP1200394B1 Process for preparing acids via alpha-chloroepoxy esters
09/27/2006	CN1839204A Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof
09/27/2006	CN1839116A Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst
09/26/2006	US7112554 Herbicides; broad active spectrum; on soil and above ground plant parts use
09/26/2006	CA2243316C Metal complexes that contain perfluoroalkyl, process for their production and their use in nmr diagnosis
09/21/2006	WO2006097730A1 Analogues of the azinomycins as anti-tumour agents and as prodrugs
09/21/2006	WO2006097694A2 Peptide synthesis supported by a soluble polymer
09/21/2006	US20060211860 Compounds for the treatment of Alzheimer's disease
09/21/2006	US20060211680 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis
09/21/2006	US20060211659 Novel compounds of the N-acylamino amide family, compositions comprising them and uses thereof
09/20/2006	EP1702914A1 Radio-opaque polymeric biomaterials
09/20/2006	EP1702910A1 Octahydronaphthalene derivative and medicine
09/20/2006	EP1701946A2 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
09/20/2006	CN1835914A New benzamides as PPAR[upsilon] modulators
09/20/2006	CN1835913A Propionic acid derivatives useful in the treatment of lipid disorders
09/20/2006	CN1835744A Remedy for viral disease
09/20/2006	CN1275917C Glucocorticoid receptor modulators
09/20/2006	CN1275916C Novel intermediates useful for the preparation of antihistaminic piperidine derivatives
09/19/2006	US7109377 Synthesis of combinatorial libraries of compounds reminiscent of natural products
09/19/2006	US7109371 Prostaglandin synthesis

1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 157